ICLR logo

ICLRIcon Plc

$146.18
$3.74
(2.50%)
Today
Closed $146.18
$0.00
(0.00%)
After Hours
Updated: 04:39 PM EDT
Reported EarningsMay 27
Mkt Cap$11.48B
Vol703,865.00
56

Bullish Sentiment

How do you feel about ICLR?

News
all
press releases
ICON Stock Valuation vs Peers: Is ICLR Cheap Enough?
ICLR looks cheap at 14.7x forward EPS versus peers, but 2026 guidance calls for lower revenue/EPS and a weak margin starting point.
Zacks
News Placeholder
More News
News Placeholder
ICLR Earnings Reset: What the Accounting Probe Changed
ICON plc details an accounting restatement, flags control weaknesses, and frames 2026 as a reset year amid mix-driven earnings swings.
Zacks
News Placeholder
The Cooper Companies (COO) Beats Q2 Earnings and Revenue Estimates
The Cooper Companies (COO) delivered earnings and revenue surprises of +9.67% and +2.57%, respectively, for the quarter ended April 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
News Placeholder
McIntyre Partnerships Sold Its Position in ICON Public Limited Company (ICLR). Here's Why
McIntyre Partnerships Sold Its Position in ICON Public Limited Company (ICLR). Here's Why...
Yahoo! Finance: News
News Placeholder
Sol-Gel Technologies Ltd. (SLGL) Reports Q1 Loss, Lags Revenue Estimates
SolGel Technologies (SLGL) delivered earnings and revenue surprises of +28.80% and -88.00%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
News Placeholder
ICON Reports Fourth Quarter and Full Year 2025 Results and Provides Outcome of Audit Committee Investigation
ICON plc (NASDAQ: ICLR), a world-leading clinical research organization, today reported its financial results for the fourth quarter and full year 2025, and announced the outcome of its investigation by the Audit Committee of the Board of Directors into certain accounting practices. CEO, Mr. Barry...
Business Wire
News Placeholder
ICON Schedules Fourth Quarter and Full Year 2025 Earnings Conference Call and Acknowledges Receipt of Deficiency Notice from Nasdaq
ICON plc (NASDAQ: ICLR), a world-leading clinical research organization, today announced that it will release financial results for the fourth quarter and full year 2025 results after the market closes on Wednesday, May 27, 2026. The Company will hold a conference call and webcast to discuss its...
Business Wire
News Placeholder
Auna S.A. (AUNA) Lags Q1 Earnings Estimates
Auna S.A. (AUNA) delivered earnings and revenue surprises of -72.97% and +2.42%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
News Placeholder
ICON expands US early phase research capabilities with new clinic and outpatient centres
ICON plc (NASDAQ: ICLR), a world-leading clinical research organisation, today announced the expansion of its early phase capabilities with the opening of a new, state-of-the-art Clinical Research...
Business Wire
News Placeholder
IceCure Medical Ltd. (ICCM) Reports Q1 Loss, Lags Revenue Estimates
IceCure Medical (ICCM) delivered earnings and revenue surprises of -100.00% and -54.90%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
<
1
2
...
>

Advertisement|Remove ads.